PQS Phoqus

RNS Number:3277G
Phoqus Pharmaceuticals PLC
25 October 2007





                           Phoqus Pharmaceuticals plc

                           Directors' share dealings


West Malling, UK, 25 October 2007: Phoqus Pharmaceuticals plc (AIM: PQS)
("Phoqus" or the "Company"), the drug development company, announces that on 24
October 2007, Dr Peter Johnson, Chief Financial Officer of Phoqus, transferred
68,868 ordinary shares ("Shares") in the Company to an exercising option-holder
in his capacity as nominee shareholder.

As previously announced, share options granted by the Company on 3 November 2005
were to be satisfied by the transfer of Shares held by certain institutional
shareholders. In order to facilitate the transfer of Shares to option-holders,
some of the institutional shareholders transferred Shares to Dr Peter Johnson,
Chief Financial Officer, to hold the Shares as their nominee pending exercise of
the share options by the option-holders, after which he would transfer the
relevant Shares to the exercising option-holders.

Following the above transfer of 68,868 Shares to an exercising option-holder on
24 October, 108,872 Shares are now held by Dr Johnson in his capacity as
nominee, representing 0.24 per cent of the issued share capital of the Company.
Dr Johnson's beneficial ownership of Phoqus Shares remains unchanged at 294,926
ordinary Shares, or 0.64 per cent of the issued share capital of the Company.

Enquiries:

Phoqus Pharmaceuticals plc
Suzanne Smith, Company Secretary                             Tel:   01732 870227

Nomura Code Securities Limited
Phil Walker                                                  Tel:  020 7776 1200




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAEESAAFXFEE

Phoqus (LSE:PQS)
Historical Stock Chart
From May 2024 to Jun 2024

Phoqus (LSE:PQS)
Historical Stock Chart
From Jun 2023 to Jun 2024